Literature DB >> 18421003

Nanomedicine captures cardiovascular disease.

Willem J M Mulder, Zahi A Fayad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18421003      PMCID： PMC3345200          DOI： 10.1161/ATVBAHA.108.165332

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  23 in total

Review 1.  Molecular imaging.

Authors:  R Weissleder; U Mahmood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  In vivo magnetic resonance imaging of transgene expression.

Authors:  R Weissleder; A Moore; U Mahmood; R Bhorade; H Benveniste; E A Chiocca; J P Basilion
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

3.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

Authors:  D A Sipkins; D A Cheresh; M R Kazemi; L M Nevin; M D Bednarski; K C Li
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

4.  Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.

Authors:  S G Ruehm; C Corot; P Vogt; S Kolb; J F Debatin
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

5.  Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.

Authors:  S Flacke; S Fischer; M J Scott; R J Fuhrhop; J S Allen; M McLean; P Winter; G A Sicard; P J Gaffney; S A Wickline; G M Lanza
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

6.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

Review 7.  Imaging of atherosclerotic cardiovascular disease.

Authors:  Javier Sanz; Zahi A Fayad
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

Review 8.  Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experience.

Authors:  Alejandra T Perez; Gabriel H Domenech; Cynthia Frankel; Charles L Vogel
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

9.  Tumor regression by targeted gene delivery to the neovasculature.

Authors:  John D Hood; Mark Bednarski; Ricardo Frausto; Samira Guccione; Ralph A Reisfeld; Rong Xiang; David A Cheresh
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

10.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
View more
  9 in total

1.  The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.

Authors:  Hua Zhang; Ning Li; Padmini Sirish; Lisa Mahakian; Elizabeth Ingham; Fitz-Roy Curry; Soichiro Yamada; Nipavan Chiamvimonvat; Katherine W Ferrara
Journal:  J Control Release       Date:  2012-07-07       Impact factor: 9.776

2.  Nanomedicine: action of metal nanoparticles on neuronal nitric oxide synthase-fluorimetric analysis on the mechanism for fibrillogenesis.

Authors:  E R Padayachee; A Arowolo; C G Whiteley
Journal:  Neurochem Res       Date:  2013-11-29       Impact factor: 3.996

3.  Exosome-like silica nanoparticles: a novel ultrasound contrast agent for stem cell imaging.

Authors:  Fang Chen; Ming Ma; Junxin Wang; Fang Wang; Shi-Xiong Chern; Eric Ruike Zhao; Anamik Jhunjhunwala; Sean Darmadi; Hangrong Chen; Jesse V Jokerst
Journal:  Nanoscale       Date:  2016-12-07       Impact factor: 7.790

Review 4.  Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.

Authors:  Fang Chen; Ghanim Hableel; Eric Ruike Zhao; Jesse V Jokerst
Journal:  J Colloid Interface Sci       Date:  2018-02-20       Impact factor: 8.128

5.  Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles.

Authors:  Pedro M Valencia; Mikhail H Hanewich-Hollatz; Weiwei Gao; Fawziya Karim; Robert Langer; Rohit Karnik; Omid C Farokhzad
Journal:  Biomaterials       Date:  2011-06-11       Impact factor: 12.479

Review 6.  Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.

Authors:  Suresh Gadde; Katey J Rayner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09       Impact factor: 8.311

Review 7.  Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives.

Authors:  Natasha Manners; Vishnu Priya; Abhishesh Kumar Mehata; Manoj Rawat; Syam Mohan; Hafiz A Makeen; Mohammed Albratty; Ali Albarrati; Abdulkarim M Meraya; Madaswamy S Muthu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-01

8.  LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.

Authors:  Jonathan E Feig; Ines Pineda-Torra; Marie Sanson; Michelle N Bradley; Yuliya Vengrenyuk; Dusan Bogunovic; Emmanuel L Gautier; Daniel Rubinstein; Cynthia Hong; Jianhua Liu; Chaowei Wu; Nico van Rooijen; Nina Bhardwaj; Michael Garabedian; Peter Tontonoz; Edward A Fisher
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

Review 9.  Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.

Authors:  Sijumon Kunjachan; Josef Ehling; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Chem Rev       Date:  2015-07-13       Impact factor: 60.622
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.